Orphan Drug Revolution
Jim Geraghty discusses rare diseases and his book "Inside The Orphan Drug Revolution: The Promise of Patient-Centered Biotechnology.
5347 articles
Jim Geraghty discusses rare diseases and his book "Inside The Orphan Drug Revolution: The Promise of Patient-Centered Biotechnology.
Mary Dubon, Physical Medicine and Rehabilitation at Massachusetts General Hospital discusses her recent presentation at the American Academy of Physical...
Juliet Knowles, MD, PhD, pediatric neurologist at Stanford Medicine Children’s Health and assistant professor of Neurology and of Pediatrics at Stanfo...
Bernadette Hee, MD, a pulmonary/critical care medicine physician shares her experience working through COVID and how she found an outlet from the stress...
Mike Krams, Chief Quantitative Medicine Officer at Exscientia plc discusses the first clinical trial application (CTA) approval in ...
Levy, GSK Global Medical Expert, Immunology & Specialty Medicine discusses the results from a global survey of rheumatologists, nephrologists and ...
Metastatic breast cancer or mBC, also known as stage 4, cannot be cured and therefore brings a different experience than earlier stage cancer.
Ira Spector, PhD, co-founder and CEO of SFA Therapeutics, discusses the company's development of a novel platform to treat chronic, inflammation-mediate...
Graft-versus-host disease, also known as GVHD, is a life-threatening condition that can occur after an allogeneic stem cell transplant, or the transfer ...
Returning guest, Brad McElya, PharmD, Walgreens Director of Specialty Health Solutions discusses how pharmacists are uniquely positioned to provide holi...